17 ambulances fly to Israel
Following Oct 7, Israeli NGO Magen David Adom urgently needed new ambulances. They called Yoav Halper who ships ambulances by sea from the USA. On Friday afternoon, a Boeing 747 landed at Ben Gurion Airport containing the first batch of 17 ambulances donated by Americans.
Israeli startups partner to develop artificial lung
Israel’s Inspira Technologies (see previously) has now partnered with Israel’s Ennocure and its infection prevention solutions, to directly oxygenate the blood for people who struggle to breathe alone. It will accelerate the development of Inspira’s ART’s intubation device.
Positive trials of cystic fibrosis treatment
Israel’s BiomX (see previously) has reported positive initial results from its clinical trials of BX004. The treatment relieves chronic pulmonary infections in patients with cystic fibrosis. BiomX now plans to initiate a larger Phase 2/3 trial.
AI rehab for IDF soldiers
The AI-powered exercise platform of Israel’s Kemtai (see previously) has been selected by Israel’s Sheba Medical Center for physical therapy to soldiers injured in Gaza. Sheba also selected Israel’s COGNIshine (see previously) for cognitive, emotional and speech therapy.
Smart wound patches save lives
A smart wound patch developed at Haifa’s Rambam Medical Center and Israel’s Noyad Biomed at Kibbutz Lavi, protects those suffering wounds that have lost blood. The patch (called Rescue Heat) warms up to 42 degrees centigrade, to protect the patient from hypothermia.
Oct 7 victims given Israeli burns treatment
Hundreds of Israelis who suffered burn wounds on Oct 7 have been treated with pineapple stem based NexoBrid gel from Israel’s MediWound (see previously). It contains the enzyme bromelain which breaks down dead tissue in 4 hours, while preserving healthy tissue.
Liver cancer patient saved
A patient with advanced hepatocellular carcinoma (liver cancer) who participated in the Phase II trials of namodenoson from Israel’s Can-Fite (see previously) had an extremely good response. His liver function returned to normal, and he is looking forward to a good quality of life.
Clearing the airways
The LibAirty compression vest from Israel’s Synchrony Medical (see previously) has begun clinical (human) trials at the National Cystic Fibrosis Center of Sheba Medical Center, where it was developed. Synchrony’s CEO says the device is twice as effective as similar products currently on the market.
Developing RNA-based treatments for rare diseases
Israel’s Skip Therapeutics is partnering with Sheba Medical Center to develop ASO-based (short RNA sequences) treatments for rare genetic diseases. Skip's ASOs (Antisense Oligonucleotide) aim to restore the function of mutated genes in genetic disorders.
Amorphous calcium to treat IBD
Israel’s Amorphical (see previously) has adapted its amorphous calcium carbonate production technology to treat inflammatory diseases such as Crohn’s disease, multiple sclerosis, and arthritis. The mineral neutralizes the acidity within affected tissue to prevent inflammation.